Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
McKinsey
Argus Health
Cerilliant
Baxter
Cipla
Covington
Daiichi Sankyo

Generated: November 18, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Bumetanide

« Back to Dashboard

Bulk Pharmaceutical API Sources for Bumetanide

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ➤ Sign Up B3023_SIGMA ➤ Sign Up
Calbiochem ➤ Sign Up 203960 ➤ Sign Up
NovoSeek ➤ Sign Up 2471 ➤ Sign Up
MP Biomedicals ➤ Sign Up 154263 ➤ Sign Up
MolPort ➤ Sign Up MolPort-003-666-390 ➤ Sign Up
ISpharm ➤ Sign Up I06-2277 ➤ Sign Up
NIH Clinical Collection ➤ Sign Up SAM002564195 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKesson
Johnson and Johnson
Queensland Health
AstraZeneca
Accenture
Julphar
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.